151 related articles for article (PubMed ID: 35930535)
21. Association of Papillary Thyroid Carcinoma with Primary Aldosteronism.
Nakamura S; Ishimori M; Yamakita N
Intern Med; 2019 Feb; 58(4):497-504. PubMed ID: 30333389
[TBL] [Abstract][Full Text] [Related]
22. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
23. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic Efficiency of Different Screening Indexes for Primary Aldosteronism].
Li YM; Wang W; Li QR; Chen T; Mo D; Zhang TT; Zhou FL; Ren Y; Tian HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):278-286. PubMed ID: 32543130
[TBL] [Abstract][Full Text] [Related]
25. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
26. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
[TBL] [Abstract][Full Text] [Related]
27. A patient with concurrent primary aldosteronism and Page kidney.
Kuo CC; Hsu HL; Huang CY; Liu KL; Wu VC; Tsai CW; Wang WJ;
Endocrine; 2010 Aug; 38(1):6-10. PubMed ID: 20960095
[TBL] [Abstract][Full Text] [Related]
28. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
[TBL] [Abstract][Full Text] [Related]
29. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Stimpel M; Ivens K; Volkmann HP; Wambach G; Kaufmann W
Klin Wochenschr; 1989 Feb; 67(4):248-52. PubMed ID: 2648061
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of aldosterone to renin ratio calculated by plasma renin activity or plasma renin concentration in primary aldosteronism: a meta-analysis.
Liu Z; Deng X; Luo L; Li S; Li M; Deng Q; Zhong W; Luo Q
Chin Med J (Engl); 2022 Mar; 135(6):639-647. PubMed ID: 35471479
[TBL] [Abstract][Full Text] [Related]
33. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
[TBL] [Abstract][Full Text] [Related]
34. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
35. Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in hypertensive patients with primary aldosteronism.
Demirtas D; Sumbul HE; Bulut A; Demirtas AO; Gulumsek E; Koca H; Icen YK; Koc M
Clin Exp Hypertens; 2020; 42(1):93-98. PubMed ID: 31204516
[No Abstract] [Full Text] [Related]
36. Clinical characteristics of snoring patients with primary aldosteronism and obstructive sleep apnea-hypopnea syndrome.
Li M; Ge Q; Sheng CS; Zhang J; Li H; Niu W; Tang X; Xu J; Gao PJ; Wang JG; Zhu L
J Hum Hypertens; 2019 Sep; 33(9):693-700. PubMed ID: 31089199
[TBL] [Abstract][Full Text] [Related]
37. Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test.
Kita T; Furukoji E; Sakae T; Kitamura K
Hypertens Res; 2019 Jun; 42(6):801-806. PubMed ID: 30622316
[TBL] [Abstract][Full Text] [Related]
38. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD;
Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109
[TBL] [Abstract][Full Text] [Related]
39. Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension.
van Kleef MEAM; Visseren FLJ; Westerink J; Bots ML; Blankestijn PJ; van der Graaf Y; Spiering W
BMC Endocr Disord; 2020 Apr; 20(1):56. PubMed ID: 32349748
[TBL] [Abstract][Full Text] [Related]
40. Primary aldosteronism in normokalemic patients with adrenal incidentalomas.
Bernini G; Moretti A; Argenio G; Salvetti A
Eur J Endocrinol; 2002 Apr; 146(4):523-9. PubMed ID: 11916621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
